Photograph: Rex/Shutterstock
Rebekah Powers was 11 when members of her faith group, the People of Praise, gathered around as she sat on a chair and laid their hands on her to pray. Powers sister had shown a gift for speaking in tongues, a defining trait of the followers of the small charismatic Christian community, and Rebekah was expected to do the same.
Related: McConnell hits out at Guardian and other media over Amy Coney Barrett scrutiny
But after what seemed like an eternity, she proved unable to produce a sound.
I couldnt get it, and I stayed there an hour and a half before they gave up and finally said, You just have blockage. You need to just work on your sin and be more open, she said.
The 41-year-old had a rebellious spirit and left People of Praise when she turned 18. It has taken decades of therapy and hard work to overcome the intense feelings of shame and fear of damnation that she said marked her childhood. The Christian faith group, based in South Bend, Indiana, dominated every aspect of her early life, she said.
Next week, Amy Coney Barrett, a conservative appellate court judge who is a prominent member of the 1,700-member strong People of Praise, will sit before the Senate judiciary committee to face questions about her judicial philosophy as part of her controversial confirmation to take a seat on the supreme court. A successful appointment, replacing the liberal Ruth Bader Ginsburg, will cement a conservative dominance on the powerful body.
Democrats have already stated that neither Barretts Catholic faith nor her membership in the People of Praise which has never publicly been discussed or disclosed, but has been examined in press reports will be raised in their questioning of the nominee.
Mitch McConnell, the Senate majority leader who is seeking to confirm Barrett before the end of October, has nevertheless said that media reports and some remarks by senators about a newly discovered public statement by Barrett in opposition to Roe v Wade, were disgusting attacks on faith. He said they risked a return to the tropes of the 1960s, when it was feared by some anti-Catholic bigots that John F Kennedy would act in the interest of the pope instead of the US.
Story continues
Our coastal elites are so disconnected from their own country that they treat religious Americans like strange animals in a menagerie, McConnell said in a statement.
But Powers, who is one of a handful of former People of Praise members who contacted the Guardian to describe their difficult experience in the group (using her married name), and some religious scholars who have studied charismatic Christian communities, say Barretts membership in this specific religious community does raise legitimate questions. They want to examine how views that are integral to the groups core beliefs from its treatment of women to the separation of church and state might influence her. They are also distinct from most mainstream Catholic faith.
In the bi-weekly and hours-long meetings that defined Powers childhood, intense prayer and discussions centered on obedience and driving out sin. Powers, who does not know Barrett, frequently witnessed people speaking in tongues and frenzied calls for evil spirits to be expelled, episodes that usually led to exorcisms.
The brainwashing and the groupthink, the female subjugation it was so devaluing
Rebekah Powers
In the strict hierarchy exercised by the group, Powers parents were often asked to take in other members into their home, even though her own family were using food stamps to get by. As a child and teenager, Powers father served as her spiritual head and worked multiple jobs, including being asked to tend to the lawns of the communitys properties, free of charge.
Women who are married, like Barrett, count their husbands as their heads.
We were Catholic, but the Catholicism was on the side. Our life, all of our friends, all of the randoms who were living in our household, were the [People of Praise] community. It was God, she said. The brainwashing and the groupthink, the female subjugation of being there to serve and listen to your spiritual head. It was so devaluing. To me, it instilled such problems.
Powers experiences are in line with a handbook called The Spirit and Purpose of the People of Praise, which was obtained by the Guardian and confirms that people who seek to be members of the group are prayed with for the release of charismatic gifts specifically, speaking in tongues and the gift of prophecy. It also states: Obedience to authority and submission to headship are active responses to the gifts of God.
Although Barrett has not discussed the issue, there is evidence that the former Notre Dame law professor served as a trustee for a school affiliated with the group; lived in the home of a prominent co-founder when she was in law school; and announced the birth of her children in People of Praises magazine, which has removed references to Barrett and her family since she joined the federal bench in 2017.
The Washington Post reported this week that Barrett served as a handmaid as late as 2010, a leadership position for women in the community, according to a directory.
Barretts father, Mike Coney, who has served in a leadership position in the People of Praise, described his own decision to join the group in a 2018 testimonial at his Catholic church, describing how he had initially unwillingly attended a charismatic seminar as a young man. When prayed with for a greater outpouring of the Holy Spirit, nothing happened. Then later that night I began to speak in tongues. More importantly, I was filled with an insatiable appetite for reading scripture and spiritual books, he wrote.
Thomas Csordas, an anthropology professor at the University of California San Diego who has studied the issues around communities like People of Praise, said it was wrong to focus attention on whether the group could be a considered a cult in the spirit of Jim Joness Peoples Temple. It was much more appropriate, he said, to examine what he called the intentional community of People of Praise and its nature of being conservative, authoritarian, hierarchical, and patriarchal.
I think theyre potentially more dangerous and much more sophisticated [than a cult], he said. It is not the kind of group where submission of women to men means that they have to stay barefoot and pregnant. Instead, they have to be lawyers and judges and submissive to men at the same time. They have to be able to have a career and seven kids at the same time.
Far from taking her cues from the People of Praise, Csordas said, Barretts biography showed she was not a mindless devotee of a cult, but rather part of the elite of the intentional charismatic covenant community, reflecting her previous status as a handmaiden and trustee of the school, and her fathers leadership role.
Related: Revealed: Amy Coney Barrett lived in home of secretive Christian groups co-founder
Contrary to a situation in which people might worry she might be told what to think or told by her husband. Being that far into the community means, no, she is going to be teaching other people. She already knows what to think because of the patriarchal structure she was raised in, which mirrors conservative Catholic views and the views of her judicial mentor, Antonin Scalia.
Massimo Faggioli, a professor of theology at Villanova University, said that even if senators declined to question Barrett about her faith, the issues deserved to be aired in other forums because groups like People of Praise, he said, does reject a secular view of separation between church and state.
I dont think we should put her Catholicism on trial, but the Catholic conservative legal movement is putting liberalism on trial. They want to change a certain understanding of the liberal order of individual rights, and that is coming from the religious worldview of Catholic groups, he said.
Maybe not in the Senate, but in the public square.
A spokesman for People of Praise has said it would be inappropriate to discuss Barrett. He has also said the organization is an ecumenical community that strives to allow men and women with a wide variety of political and religious views to live together in harmony.
See original here:
The Crypto Daily Movers and Shakers October 10th, 2020 - Sports Grind Entertainment
- Hannah just thought she was being clumsy, but her bruises were a sign she needed to see her doctor - Daily Mail - October 27th, 2023
- Brent Rutemiller's Cancer In Early Remission After 42 Weeks of Chemotherapy and Stem Cell Transplant - Swimming World Magazine - May 20th, 2022
- Other Notable Health Studies & Research From May 17, 2022 - Study Finds - May 20th, 2022
- Clinton County Relay For Life holds annual event in Riverview Park - Lock Haven Express - May 20th, 2022
- Illinois Is Being Invaded By Worms That Jump A Foot In The Air - 1440wrok.com - May 20th, 2022
- Moderna, J&J COVID Booster Shots Near Authorization. Here's What to Know - NBC Chicago - October 26th, 2021
- GenFleet Announces First Patient Dosed in Phase Ib/II Trial of TGF- R1 Inhibitor in Combination with PD-1 Inhibitor in Global Multi-center Research -... - October 26th, 2021
- Merck Provides Update on KEYTRUDA (pembrolizumab) Indication in Third-Line Gastric Cancer in the US - Business Wire - July 6th, 2021
- Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and Commercialize ex vivo autologous HSC Gene - GlobeNewswire - July 6th, 2021
- New global guidelines for stem cell research aim to drive discussions, not lay down the law - The Conversation AU - May 27th, 2021
- Merck (MRK) Granted Positive EU CHMP Opinion for KEYTRUDA (pembrolizumab) in Combination with Chemotherapy - StreetInsider.com - May 27th, 2021
- Merck Receives Positive EU CHMP Opinion for KEYTRUDA in Combination With Chemotherapy as First-Line Treatment for Certain Patients With Esophageal... - May 27th, 2021
- Epigenetic therapies for heart failure | VHRM - Dove Medical Press - May 27th, 2021
- OPDIVO (nivolumab) in Combination with CABOMETYX (cabozantinib) Shows Sustained Survival and Response Rate Benefits as First-Line Treatment for... - February 14th, 2021
- AlloVir Research Presented at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience - Business Wire - February 14th, 2021
- Opdivo in Combination with Cabometyx Shows Sustained Survival and Response Rate Benefits as First-Line Treatment for Patients with Advanced RCC -... - February 14th, 2021
- Astellas and Seagen Announce Presentation of Results from PADCEV (enfortumab vedotin-ejfv) Pivotal Trial in Patients with Previously Treated Advanced... - February 14th, 2021
- [Full text] Loganin Attenuates Septic Acute Renal Injury with the Participation of | DDDT - Dove Medical Press - February 14th, 2021
- [Full text] Encephalopathy Induced by Preventive Administration of Acyclovir in a | IJGM - Dove Medical Press - February 14th, 2021
- Joint inflammation: Causes, treatment, and symptoms - Medical News Today - February 14th, 2021
- Creative Medical Technology Holdings Identifies and Files Patent on Novel Mechanism of ImmCelz Therapeutic Activity - PRNewswire - February 3rd, 2021
- How Coronavirus Damages Lung Cells Within Mere Hours And What Drugs Could Halt COVID-19 Infection - SciTechDaily - February 3rd, 2021
- Mini kidneys bioprinted in the lab - Lab + Life Scientist - December 4th, 2020
- Telix Pharmaceuticals Limited Acquires TheraPharm GmbH, Broadening Reach to Hematologic Cancers and Transplant Medicine - BioSpace - December 4th, 2020
- News briefing: Four biotechs announce IPO terms, setting the pace to round out a busy year; FDA sets PDUFA date for Kadmon's graft-versus-host drug -... - December 4th, 2020
- Government of Canada and JDRF Canada announce new research funding to accelerate stem cell-based therapies for type 1 diabetes - Philippine Canadian... - December 4th, 2020
- Merck Announces KEYNOTE-598 Trial Evaluating KEYTRUDA in Combination With Ipilimumab Versus KEYTRUDA Monotherapy in Certain Patients With Metastatic... - November 11th, 2020
- KEYTRUDA (pembrolizumab) Plus LENVIMA (lenvatinib) Demonstrated Statistically Significant Improvement in Progression-Free Survival (PFS), Overall... - November 11th, 2020
- Gilead and Kite to Share Latest Scientific Advances in Hematologic Malignancies at ASH 2020 - Investing News Network - November 11th, 2020
- The great reset: new danger on the horizon - Amandala - November 11th, 2020
- Teladoc Is A Strong Buy: A Radical Healthcare Change Will Come - Seeking Alpha - November 11th, 2020
- COVID Drug Given to Trump Developed From Aborted Fetus Cells - Quint Fit - October 10th, 2020
- Lars Jaeger: The Future is Veggie, With 3D Printing - finews.asia - October 10th, 2020
- Laid off from ImmunoGen, an ex-Genzyme and Shire exec heads to an ARCH upstart - Endpoints News - October 10th, 2020
- 5 Deadly Pre-existing Conditions You Could Have Due To COVID-19 - Brumpost - Brumpost - October 10th, 2020
- Coronavirus Tracker: Bexar Co. cases surpass 59,000; Texas hospitalizations trending in the wrong direction - KENS5.com - October 10th, 2020
- Ligand Announces its Captisol Business is Positioned for Major Growth and Forecasts 2021 Captisol Material Sales of $200 Million - Business Wire - September 24th, 2020
- Seattle Genetics and Merck Announce Two Strategic Oncology Collaborations - BioSpace - September 15th, 2020
- Alexion and Caelum Biosciences Announce Start of Phase 3 Studies of CAEL-101 in AL Amyloidosis - Business Wire - September 15th, 2020
- Braunstein Reflects on the Rise of Quadruplet Therapies in Multiple Myeloma - OncLive - September 9th, 2020
- Roche receives FDA clearance for BK virus quantitative test on cobas 6800/8800 Systems to support better care for transplant patients - GlobeNewswire - September 9th, 2020
- ASX Biotechs Surfing The Covid Story - FN Arena News - August 16th, 2020
- Merck and Eisai Receive Complete Response Letter for KEYTRUDA (pembrolizumab) plus LENVIMA (lenvatinib) Combination as First-Line Treatment for... - July 10th, 2020
- FDA Approves Talaris Therapeutics' IND for Its Allogeneic Cell Therapy FCR001 to Be Evaluated in Patients With a Severe Form of Scleroderma - Business... - July 10th, 2020
- Coronavirus PPP Loans In Livingston: Where The Money Went - Livingston, NJ Patch - July 9th, 2020
- Stem Cell Therapy For Kidney Failure. Learn More Now ... - July 7th, 2020
- Anemia in chronic kidney disease - kidneyfund.org - July 7th, 2020
- Dr Borehams Crucible: Mesoblast within months of 3 major trial results, key regulatory decision - Stockhead - July 7th, 2020
- FDA Approves Merck's KEYTRUDA (pembrolizumab) for First-Line Treatment of Patients With Unresectable or Metastatic MSI-H or dMMR Colorectal Cancer -... - June 30th, 2020
- R3 International Offering Stem Cell Therapy Program for Anti Aging in Mexico - PR Web - June 30th, 2020
- Vitro Bio-Pharma 2nd Quarter Ended April 30th 2020 Financial Results of Operations and Shareholder Letter - Stockhouse - June 30th, 2020
- FDA Approves Merck's KEYTRUDA (pembrolizumab) for the Treatment of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) that... - June 25th, 2020
- Simcha Therapeutics Launches to Engineer Therapeutic Cytokines to Unlock the Full Potential of the Immune System - Business Wire - June 25th, 2020
- First American to Receive Placental Cell Treatment For COVID-19 is an Acclaimed Broadway Scenic Designer - Science Times - May 27th, 2020
- Scientists generate millions of mature human cells, far more than have ever been produced - UB News Center - May 20th, 2020
- Heres The Reason Why Scientists Are Growing Human Cells In Mouse Embryo - Medical Daily - May 20th, 2020
- Cell therapies trial planned for COVID-19 - Mirage News - May 5th, 2020
- New Study Finds That Wearing Contact Lenses Doesn't Increase Risk of COVID-19 Infection - HealthDay Coronavirus Liveblog - April 26th, 2020
- Israeli COVID-19 treatment with 100% survival rate tested on US patient - The Jerusalem Post - April 15th, 2020
- Stem Cells and Chronic Kidney Disease | Mayo Clinic Center ... - April 11th, 2020
- Kidney Failure | Stem Cell Treatment in Tijuana Mexico - April 11th, 2020
- MESOBLAST PARTNERS WITH THE CARDIOTHORACIC SURGICAL TRIALS NETWORK ESTABLISHED BY THE U.S. NATIONAL INSTITUTES OF HEALTHS NATIONAL HEART, LUNG AND... - April 11th, 2020
- Merck Receives Priority Review from FDA for Second Application for KEYTRUDA (pembrolizumab) Based on Biomarker, Regardless of Tumor Type - Benzinga - April 11th, 2020
- A coronavirus vaccine is being developed in record time. But dont expect that technology to speed up flu vaccines yet. - Columbia Daily Herald - April 7th, 2020
- Researchers test drug that stops early stages of COVID-19 - Open Access Government - April 7th, 2020
- Can cell-based therapy be helpful in tackling coronavirus? - YourStory - March 25th, 2020
- Made-in-space organs could soon be reality - ETHealthworld.com - March 13th, 2020
- What Is the Coronavirus? - WIRED - March 6th, 2020
- 34 years with a new heart and counting - MDJOnline.com - February 25th, 2020
- Coronavirus: Doctors try 3,000-year-old Traditional Chinese Medicine (TCM) to treat the virus - Times of India - February 20th, 2020
- Merck's KEYTRUDA (pembrolizumab) in Combination with Chemotherapy Met Primary Endpoint of Progression-Free Survival (PFS) as First-Line Treatment for... - February 14th, 2020
- Seattle Genetics and Astellas Announce Updated Results from Phase 1b/2 Trial of PADCEV (enfortumab vedotin-ejfv) in Combination with Immune Therapy... - February 14th, 2020
- Omeros: 2 Major Catalysts On The Horizon - Seeking Alpha - February 10th, 2020
- Cambridge Science Festival showcases new research at the forefront of healthcare and medicine - Cambridge Network - February 10th, 2020
- Anemia: Causes, symptoms and treatment - Livescience.com - February 8th, 2020
- 4 Crazy but Effective Ways to Save More Money This Year - Nasdaq - February 4th, 2020
- BAME lives to be saved as new organ donation law rolls out - Keep the Faith - January 15th, 2020
- HIV drug resistance an emerging threat, expert warns - DAWN.com - January 10th, 2020
- A Lasting Legacy: DuPont, C8 Contamination and the Community Left to Grapple With the Consequences - alleghenyfront.org - January 10th, 2020
- Merck's KEYTRUDA (pembrolizumab) in Combination with Chemotherapy Significantly Improved Progression-Free Survival Compared to Chemotherapy Alone as... - January 6th, 2020